Published in Redox Biol on January 26, 2013
Lysyl oxidase is associated with increased thrombosis and platelet reactivity. Blood (2016) 1.41
Deubiquitinases Modulate Platelet Proteome Ubiquitination, Aggregation, and Thrombosis. Arterioscler Thromb Vasc Biol (2015) 1.39
Lipopolysaccharide stimulates platelets through an IL-1β autocrine loop. J Immunol (2013) 0.91
Proteasome proteolysis supports stimulated platelet function and thrombosis. Arterioscler Thromb Vasc Biol (2013) 0.85
The effect of ferric chloride on superficial bleeding. Trauma Mon (2015) 0.79
Use of ferric sulfate to control hepatic bleeding. Trauma Mon (2015) 0.79
Exosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-atherothombotic cellular functions. J Thromb Haemost (2014) 0.78
Launch of Redox Biology: A new venue for studies in translational, basic and applied research in the fields of antioxidants, cell signaling and redox therapeutics. Redox Biol (2013) 0.77
Non-invasive imaging and cellular tracking of pulmonary emboli by near-infrared fluorescence and positron-emission tomography. Nat Commun (2015) 0.77
Thymidine phosphorylase participates in platelet signaling and promotes thrombosis. Circ Res (2014) 0.77
Inflammation in atherosclerosis. Nature (2002) 28.92
The burden and costs of chronic diseases in low-income and middle-income countries. Lancet (2007) 8.33
Rat model of arterial thrombosis induced by ferric chloride. Thromb Res (1990) 2.32
Mechanisms underlying FeCl3-induced arterial thrombosis. J Thromb Haemost (2011) 2.18
Murine thrombosis models. Thromb Haemost (2004) 1.98
Vav guanine nucleotide exchange factors link hyperlipidemia and a prothrombotic state. Blood (2011) 1.79
Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice. J Clin Invest (2008) 1.77
Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. J Mol Cell Cardiol (2009) 1.74
Murine models of vascular thrombosis (Eitzman series). Arterioscler Thromb Vasc Biol (2007) 1.74
Advanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36. Blood (2012) 1.69
A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein. Circ Res (2008) 1.66
Clinical aspects of platelet inhibitors and thrombus formation. Circ Res (2007) 1.42
CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs. J Clin Invest (2010) 1.41
Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice. Circulation (2001) 1.39
Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury. Blood (2008) 1.32
Mechanisms of cell signaling by the scavenger receptor CD36: implications in atherosclerosis and thrombosis. Trans Am Clin Climatol Assoc (2010) 1.27
Atherosclerosis and thrombosis: insights from large animal models. J Biomed Biotechnol (2011) 1.15
Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury. J Biol Chem (2009) 1.10
Towards a standardization of the murine ferric chloride-induced carotid arterial thrombosis model. J Thromb Haemost (2011) 0.99
Deficiency of LRP8 in mice is associated with altered platelet function and prolonged time for in vivo thrombosis. Thromb Res (2008) 0.98
Assessment of thrombin inhibitor efficacy in a novel rabbit model of simultaneous arterial and venous thrombosis. Thromb Haemost (1998) 0.96
Model systems of genetically modified platelets. Blood (2011) 0.96
Overview of murine thrombosis models. Thromb Res (2008) 0.91
The year in atherothrombosis. J Am Coll Cardiol (2012) 0.85
Murine models of thrombosis. Thromb Res (2012) 0.84
Circulating biologically active oxidized phospholipids show on-going and increased oxidative stress in older male mice. Redox Biol (2013) 0.83
Ultrastructure of a model of thrombogenesis induced by mechanical injury. J Submicrosc Cytol (1981) 0.82
Pharmacodynamic activity and antithrombotic efficacy of RPR120844, a novel inhibitor of coagulation factor Xa. J Cardiovasc Pharmacol (1999) 0.78